August 2024

 

We are happy to share the news on receiving InnoBooster grant by Innovation Fond Denmark, and Eurostars programme. In the next 3 years we will be working further on preclinical development and deeper understanding of our lead candidate for RA, APT001.

The consortium of Eurostars project includes KOL in RA Karolinska Institute, Sweden, and excellent partner for in vivo studies, Naason, South Korea.

​

​

​